Safety Study of Microlyte DualGuard

The primary purpose of this research is to evaluate the safety and effectiveness of Microlyte® DualGuard wound dressing in the healing of partial thickness donor site wounds, also known as skin graft donor sites. This research will assess wound healing, the occurrence of infection, allergic reaction, pain, and itching while subjects are in the hospital and after discharge. Subjects will complete clinic visits through 12 weeks. This research will also assess the occurrence of donor site wound infection, pain and itching, and scarring at 12 weeks, assessed by subjects using the Patient and Observer Scar Assessment Scale (POSAS).

NCT Number	NCT07695688
Lead Sponsor	Imbed Biosciences Collaborators: United States Department of Defense
Conditions	Wound Closure, Wound Care
Enrollment	53 participants
Start Date	2026-08-30
Primary Completion	2027-04 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-10